Skip to main content
Year archive

Akebia Therapeutics, Inc. — 2023 filings

All 87 regulatory filings released by Akebia Therapeutics, Inc. (AKBA) in 2023, sourced directly from the official regulator.

87 Filings
2023 Period
2023 filings (87)
Filing Released Lang
8-K
Regulatory Filings
2023-12-18 English
8-K
Regulatory Filings
2023-11-21 English
Interim / Quarterly Report Q3 2023
2023-11-08 English
8-K
Earnings Release
2023-11-08 English
8-K
Capital/Financing Update
2023-11-02 English
8-K
Regulatory Filings
2023-10-25 English
8-K
Board/Management Information
2023-10-12 English
8-K
Regulatory Filings
2023-09-26 English
Interim / Quarterly Report Q2 2023
2023-08-28 English
Annual Report FY 2022
2023-08-28 English
8-K
Earnings Release
2023-08-25 English
8-K
Regulatory Filings
2023-08-17 English
8-K
Regulatory Filings
2023-08-11 English
Regulatory Filings
2023-08-10 English
Director's Dealing
2023-08-01 English
8-K
Board/Management Information
2023-08-01 English
Director's Dealing
2023-07-18 English
8-K
Regulatory Filings
2023-07-18 English
8-K
Board/Management Information
2023-06-13 English
8-K
Declaration of Voting Results & Voting Rights Announcements
2023-06-08 English
Director's Dealing
2023-06-08 English
Director's Dealing
2023-06-08 English
Director's Dealing
2023-06-08 English
Director's Dealing
2023-06-08 English
Director's Dealing
2023-06-08 English
Director's Dealing
2023-06-08 English
Director's Dealing
2023-06-08 English
8-K
Investor Presentation
2023-06-07 English
S-8
Capital/Financing Update
2023-06-06 English
8-K
Regulatory Filings
2023-06-02 English
8-K
Regulatory Filings
2023-05-31 English
8-K
Regulatory Filings
2023-05-30 English
Director's Dealing
2023-05-25 English
Director's Dealing
2023-05-25 English
Regulatory Filings
2023-05-25 English
Regulatory Filings
2023-05-25 English
8-K
Regulatory Filings
2023-05-25 English
8-K
Regulatory Filings
2023-05-23 English
Director's Dealing
2023-05-18 English
Director's Dealing
2023-05-18 English
Regulatory Filings
2023-05-16 English
Regulatory Filings
2023-05-16 English
Director's Dealing
2023-05-16 English
Director's Dealing
2023-05-16 English
8-K
Delisting Announcement
2023-05-09 English
Interim / Quarterly Report Q1 2023
2023-05-08 English
8-K
Earnings Release
2023-05-08 English
8-K
Declaration of Voting Results & Voting Rights Announcements
2023-05-08 English
ARS
Annual Report
2023-04-28 English
Proxy Solicitation & Information Statement
2023-04-28 English
8-K
Board/Management Information
2023-04-28 English
8-K
Regulatory Filings
2023-04-25 English
Proxy Solicitation & Information Statement
2023-04-21 English
Proxy Solicitation & Information Statement
2023-04-14 English
Proxy Solicitation & Information Statement
2023-04-14 English
Remuneration Information
2023-04-11 English
8-K
Regulatory Filings
2023-04-11 English
Proxy Solicitation & Information Statement
2023-03-31 English
Proxy Solicitation & Information Statement
2023-03-27 English
Remuneration Information
2023-03-27 English
Proxy Solicitation & Information Statement
2023-03-27 English
Proxy Solicitation & Information Statement
2023-03-24 English
Proxy Solicitation & Information Statement
2023-03-17 English
Annual Report FY 2022
2023-03-10 English
8-K
Regulatory Filings
2023-03-09 English
Director's Dealing
2023-03-03 English
Director's Dealing
2023-03-03 English
Director's Dealing
2023-03-03 English
Director's Dealing
2023-03-03 English
Director's Dealing
2023-03-03 English
8-K
Regulatory Filings
2023-03-02 English
Director's Dealing
2023-03-01 English
Director's Dealing
2023-03-01 English
Director's Dealing
2023-03-01 English
Proxy Solicitation & Information Statement
2023-03-01 English
Director's Dealing
2023-03-01 English
Director's Dealing
2023-03-01 English
8-K
Regulatory Filings
2023-02-21 English
Proxy Solicitation & Information Statement
2023-02-17 English
Major Shareholding Notification
2023-02-10 English
Major Shareholding Notification
2023-02-09 English
Director's Dealing
2023-02-02 English
Director's Dealing
2023-02-02 English
Director's Dealing
2023-02-02 English
S-8
Regulatory Filings
2023-01-30 English
Major Shareholding Notification
2023-01-20 English
8-K
Investor Presentation
2023-01-09 English